Secondary and therapy-related acute myeloid leukemias: Overlapping features, distinct trajectories.
Sign Up to like & getrecommendations! Published in 2025 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2025.06.005
Abstract: Therapy-related acute myeloid leukemia (tAML) and AML arising from previous hematologic disorders (secondary AML, sAML) share similar biological features, including karyotype abnormalities and gene specific mutations, patient-related risk factors. Older age and lower performance status… read more here.
Keywords: therapy related; acute myeloid; secondary therapy; related acute ... See more keywords
Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population
Sign Up to like & getrecommendations! Published in 2019 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofz028
Abstract: Abstract We retrospectively evaluated off-label use of dalbavancin as secondary therapy in 32 patients with serious Staphylococcus aureus infections (endocarditis, osteomyelitis, septic thrombophlebitis, epidural infection) who were also persons who use drugs. The majority of… read more here.
Keywords: staphylococcus aureus; secondary therapy; serious staphylococcus; aureus infections ... See more keywords